Trabajos de Eva Ciruelos

Clinical Medicine


  Listando 46 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   3   Wikipedia   50   News   0   Policy
Article Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer Andre, Fabrice; Ciruelos, Eva; Rubovszky, Gabor; Campone, Mario; Loibl, Sibylle; Rugo, Hope S.; Iwata, Hiroji; Conte, Pierfranco; Mayer, Ingrid A.; Kaufman, Bella; Yamashita, Toshinari; Lu, Yen-Shen; Inoue, Kenichi; Takahashi, Masato; Papai, Zsuzsanna; Lon NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2019) DOI / 10.1056/nejmoa1813904 Bronze
Mentions   0   Wikipedia   16   News   0   Policy
Article Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial Pernas, Sonia; Martin, Miguel; Kaufman, Peter A.; Gil-Martin, Marta; Gomez Pardo, Patricia; Lopez-Tarruella, Sara; Manso, Luis; Ciruelos, Eva; Alejandro Perez-Fidalgo, Jose; Hernando, Cristina; Ademuyiwa, Foluso O.; Weilbaecher, Katherine; Mayer, Ingrid; P LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(18)30147-5
Mentions   0   Wikipedia   9   News   0   Policy
Article Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer, LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30786-7
Mentions   0   Wikipedia   0   News   0   Policy
Article Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-20-0844
Mentions   1   Wikipedia   8   News   1   Policy
Article Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Swain, Sandra M.; Miles, David; Kim, Sung-Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefania; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortes, Javier LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30863-0
Mentions   0   Wikipedia   1   News   0   Policy
Article Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study Rugo, Hope S.; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-ming LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(21)00034-6
Mentions   0   Wikipedia   0   News   0   Policy
Article Gene expression profiles of breast cancer metastasis according to organ site Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa MOLECULAR ONCOLOGY 1574-7891 (2021) DOI / 10.1002/1878-0261.13021 Gold DOAJ
Mentions   0   Wikipedia   1   News   0   Policy
Article TNeoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Pena, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M.; Vuylsteke, Peter; Castaneda, Carlos A.; Colleoni, Marco; Bor LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30334-1
Mentions   0   Wikipedia   3   News   0   Policy
Article Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer Huober, Jens; Holmes, Eileen; Baselga, Jose; de Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Lecocq, Christophe; Wildiers, Hans; Jouannaud, Christelle; Hackman, John; Dasappa, L EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2019.04.038
Mentions   0   Wikipedia   0   News   0   Policy
Article Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin EBIOMEDICINE 2352-3964 (2021) DOI / 10.1016/j.ebiom.2021.103451 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael NATURE COMMUNICATIONS (2020) DOI / 10.1038/s41467-019-14111-3 Gold DOAJ, Green published
Mentions   0   Wikipedia   3   News   0   Policy
Article Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1 Maria Ciruelos, Eva; Rugo, Hope S.; Mayer, Ingrid A.; Levy, Christelle; Forget, Frederic; Delgado Mingorance, Juan Ignacio; Safra, Tamar; Masuda, Norikazu; Park, Yeon Hee; Juric, Dejan; Conte, Pierfranco; Campone, Mario; Loibl, Sibylle; Iwata, Hiroji; Zhou JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.01139 Hybrid
Mentions   0   Wikipedia   4   News   0   Policy
Article Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E. M.; Munoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csoszi, T.; Casas, M., I; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2020.12.013 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Anna Belen; Schettini, Francesco; Conte, Benedetta; Vidal, Maria; Adamo, Bar NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00218-8 Gold DOAJ, Green published
Mentions   0   Wikipedia   3   News   0   Policy
Article SEOM clinical guidelines in early stage breast cancer (2018) Ayala de la Pena, F.; Andres, R.; Garcia-Saenz, J. A.; Manso, L.; Margeli, M.; Dalmau, E.; Pernas, S.; Prat, A.; Servitja, S.; Ciruelos, E. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2019) DOI / 10.1007/s12094-018-1973-6 Green published, Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer Prat, Aleix; Tsai, Yi-Hsuan; Pascual, Tomas; Pare, Laia; Adamo, Barbara; Vidal, Maria; Braso-Maristany, Fara; Galvan, Patricia; Brase, Jan Christoph; Rodrik-Outmezguine, Vanessa; Johnston, Stephen; Ciruelos, Eva; Parker, Joel S. CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-20-2793
Mentions   0   Wikipedia   4   News   0   Policy
Article Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer Rugo, H. S.; Andre, F.; Yamashita, T.; Cerda, H.; Toledano, I; Stemmer, S. M.; Jurado, J. C.; Juric, D.; Mayer, I; Ciruelos, E. M.; Iwata, H.; Conte, P.; Campone, M.; Wilke, C.; Mills, D.; Lteif, A.; Miller, M.; Gaudenzi, F.; Loibl, S. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.05.001 Gold other
Mentions   2   Wikipedia   3   News   1   Policy
Article Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lonning, Per E.; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel; Csoszi, Tibor; Bordonaro, Roberto; Decker, Thomas; Tjan-Heijnen, Vivianne C. G.; Bl LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(17)30688-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial Adamo, Barbara; Bellet, Meritxell; Pare, Laia; Pascual, Tomas; Vidal, Maria; Perez Fidalgo, Jose A.; Blanch, Salvador; Martinez, Noelia; Murillo, Laura; Gomez-Pardo, Patricia; Lopez-Gonzalez, Ana; Amillano, Kepa; Canes, Jordi; Galvan, Patricia; Gonzalez-Fa BREAST CANCER RESEARCH 1465-542X (2019) DOI / 10.1186/s13058-019-1195-z Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.638482 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor BMC MEDICINE 1741-7015 (2019) DOI / 10.1186/s12916-018-1233-1 Green published, Gold
Mentions   0   Wikipedia   4   News   0   Policy
Article Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2enegative advanced breast cancer: final overall survival results from SOLAR-1 Andre, F.; Ciruelos, E. M.; Juric, D.; Loibl, S.; Campone, M.; Mayer, I. A.; Rubovszky, G.; Yamashita, T.; Kaufman, B.; Lu, Y-S; Inoue, K.; Papai, Z.; Takahashi, M.; Ghaznawi, F.; Mills, D.; Kaper, M.; Miller, M.; Conte, P. F.; Iwata, H.; Rugo, H. S. ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2020.11.011 Hybrid
Mentions   0   Wikipedia   3   News   0   Policy
Article Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study Kahan, Zsuzsanna; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Casas, Maribel; Csoszi, Tibor; Murillo, Laura; Morales, Serafin; Calvo, Lourdes; Lang, Istvan; Alba, EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.07.004 Hybrid
Mentions   0   Wikipedia   1   News   0   Policy
Article Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1(E17K)-Mutant, ER-Positive Metastatic Breast Cancer Smyth, Lillian M.; Tamura, Kenji; Oliveira, Mafalda; Ciruelos, Eva M.; Mayer, Ingrid A.; Sablin, Marie-Paule; Biganzoli, Laura; Ambrose, Helen J.; Ashton, Jack; Barnicle, Alan; Cashell, Des D.; Corcoran, Claire; de Bruin, Elza C.; Foxley, Andrew; Hauser, J CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3953 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2 Prat, Aleix; Christoph Brase, Jan; Cheng, Yuan; Nuciforo, Paolo; Pare, Laia; Pascual, Tomas; Martinez, Debora; Galvan, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, Jose; Ciruelos, Eva ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0407 Green published, Bronze
Mentions   0   Wikipedia   0   News   1   Policy
Article Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) Bachelot, T.; Ciruelos, E.; Schneeweiss, A.; Puglisi, F.; Peretz-Yablonski, T.; Bondarenko, I.; Paluch-Shimon, S.; Wardley, A.; Merot, J. -l.; du Toit, Y.; Easton, V.; Lindegger, N.; Miles, D.; Bouzid, Kamel; Campone, Mario; Coudert, Bruno; Nowecki, Zbigni ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz061 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study Gavila, J.; de la Haba, J.; Bermejo, B.; Rodriguez-Lescure, A.; Anton, A.; Ciruelos, E.; Brunet, J.; Munoz-Couselo, E.; Santisteban, M.; Rodriguez Sanchez, C. A.; Santaballa, A.; Sanchez Rovira, P.; Garcia Saenz, J. A.; Ruiz-Borrego, M.; Guerrero-Zotano, A CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-019-02145-4
Mentions   0   Wikipedia   0   News   0   Policy
Review Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer Martin, Miguel; Garcia-Saenz, Jose A.; Manso, Luis; Llombart, Antonio; Cassinello, Alejo; Atienza, Manuel; Ringeisen, Francois; Ciruelos, Eva FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0604 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer Garrido-Castro, Ana C.; Saura, Cristina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begona; Gavila, Joaquin; Serra, Violeta; Prat, Aleix; Pare, Laia; Celiz, Pamela; Villagrasa, Patricia; Li, Yisheng; Savoie, Jennifer; Xu, Zhan; Arteaga, Car BREAST CANCER RESEARCH 1465-542X (2020) DOI / 10.1186/s13058-020-01354-y Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I; Andersen, J.; Passos-Coelho, J. L.; Gil Gil, M.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; de la Pena, L.; Xu, N.; Wongchenko, M.; Shi, Z.; Singel, S. M.; Isakoff, S. J. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz177 Bronze
Mentions   0   Wikipedia   0   News   1   Policy
Article Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain Ciruelos, E.; Vidal, M.; Martinez De Duenas, E.; Martinez-Janez, N.; Fernandez, Y.; Garcia-Saenz, J. A.; Murillo, L.; Carabantes, F.; Beliera, A.; Fonseca, R.; Gavila, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1784-1
Mentions   0   Wikipedia   0   News   0   Policy
Article Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study Schettini, Francesco; Sobhani, Navid; Ianza, Anna; Triulzi, Tiziana; Molteni, Alfredo; Lazzari, Maria Chiara; Strina, Carla; Milani, Manuela; Corona, Silvia Paola; Sirico, Marianna; Bernocchi, Ottavia; Giudici, Fabiola; Cappelletti, Maria Rosaria; Ciruelos BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2020) DOI / 10.1007/s10549-020-05856-3 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer Pascual, Tomas; Apellaniz-Ruiz, Maria; Pernaut, Cristina; Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina; Ciruelos, Eva PLOS ONE 1932-6203 (2017) DOI / 10.1371/journal.pone.0180192 Green submitted, Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology Colomer, R.; Aranda-Lopez, I.; Albanell, J.; Garcia-Caballero, T.; Ciruelos, E.; Lopez-Garcia, M. A.; Cortes, J.; Rojo, F.; Martin, M.; Palacios-Calvo, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1800-5 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07) Ciruelos, Eva M.; Montano, Alvaro; Rodriguez, Cesar A.; Gonzalez-Flores, Encarnacion; Lluch, Ana; Garrigos, Laia; Quiroga, Vanesa; Anton, Antonio; Malon, Diego; Chacon, Jose, I; Velasco, Montserrat; Gonzalez-Cortijo, Lucia; Jolis, Laura; Echarri, Maria J.; EUROPEAN JOURNAL OF CANCER CARE 0961-5423 (2020) DOI / 10.1111/ecc.13253
Mentions   0   Wikipedia   0   News   0   Policy
Review Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients Cortes, Javier; Ciruelos, Eva.; Perez-Garcia, Jose; Albanell, Joan; Garcia-Estevez, Laura; Ruiz-Borrego, Manuel; Espinosa, Ruth; Gallegos, Isabel; Gonzalez, Santiago; Alvarez, Isabel; Llombart, Antonio CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2019.101944
Mentions   0   Wikipedia   0   News   0   Policy
Article A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM) Gonzalez, A.; Lluch, A.; Aba, E.; Albanell, J.; Anton, A.; Alvarez, I.; Ayala, F.; Barnadas, A.; Calvo, L.; Ciruelos, E.; Cortes, J.; de la Haba, J.; Lopez-Vega, J. M.; Martinez, E.; Munoz, M.; Pelaez, I.; Redondo, A.; Rodriguez, A.; Rodriguez, C. A.; Ruiz CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1571-4
Mentions   0   Wikipedia   0   News   0   Policy
Article Functional proteomics outlines the complexity of breast cancer molecular subtypes Gamez-Pozo, Angelo; Trilla-Fuertes, Lucia; Berges-Soria, Julia; Selevsek, Nathalie; Lopez-Vacas, Rocio; Diaz-Almiron, Mariana; Nanni, Paolo; Arevalillo, Jorge M.; Navarro, Hilario; Grossmann, Jonas; Gaya Moreno, Francisco; Gomez Rioja, Ruben; Prado-Vazquez SCIENTIFIC REPORTS 2045-2322 (2017) DOI / 10.1038/s41598-017-10493-w Green published, Green accepted, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Ne Ciruelos, Eva; Apellaniz-Ruiz, Maria; Cantos, Blanca; Martinez-Janez, Noelia; Bueno-Muino, Coralia; Echarri, Maria-Jose; Enrech, Santos; Guerra, Juan-Antonio; Manso, Luis; Pascual, Tomas; Dominguez, Cristina; Gonzalo, Juan-Francisco; Sanz, Juan-Luis; Rodri ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2017-0664 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer Maria Ciruelos, Eva; Nieves Diaz, Maria; Dolores Isla, Maria; Lopez, Rafael; Bernabe, Reyes; Gonzalez, Encarnacion; Cirauqui, Beatriz; Coves, Juan; Morales, Serafin; Arcediano, Alberto; Barneto, Isidoro; Cerezuela, Pablo; Juan Illarramendi, Jose; Morales, EUROPEAN JOURNAL OF CANCER CARE 0961-5423 (2019) DOI / 10.1111/ecc.13164
Mentions   0   Wikipedia   0   News   0   Policy
Article Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population Ciruelos, E.; Jerusalem, G.; Martin, M.; Tjan-Heijnen, V. C. G.; Neven, P.; Gavila, J.; Montemurro, F.; Generali, D.; Lang, I.; Martinez-Serrano, M. J.; Perello, M. F.; Conte, P. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02327-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study) Gonzalez-Santiago, Santiago; Saura, Cristina; Ciruelos, Eva; Luis Alonso, Jose; de la Morena, Pilar; Santisteban Eslava, Marta; Gallegos Sancho, Maria Isabel; de Luna, Alicia; Dalmau, Elsa; Servitja, Sonia; Ruiz Borrego, Manuel; Ignacio Chacon, Jose BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2020) DOI / 10.1007/s10549-020-05866-1
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer Baselga, Jose; Morales, Serafin M.; Awada, Ahmad; Blum, Joanne L.; Tan, Antoinette R.; Ewertz, Marianne; Cortes, Javier; Moy, Beverly; Ruddy, Kathryn J.; Haddad, Tufia; Ciruelos, Eva M.; Vuylsteke, Peter; Ebbinghaus, Scot; Im, Ellie; Eaton, Lamar; Pathiraj BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2017) DOI / 10.1007/s10549-017-4199-3 Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article The role of CDK4/6 inhibitors in early breast cancer Gil-Gil, Miguel; Alba, Emilio; Gavila, Joaquin; de la Haba-Rodriguez, Juan; Ciruelos, Eva; Tolosa, Pablo; Candini, Daniele; Llombart-Cussac, Antonio BREAST 0960-9776 (2021) DOI / 10.1016/j.breast.2021.05.008 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication Miles, D.; Ciruelos, E.; Schneeweiss, A.; Puglisi, F.; Peretz-Yablonski, T.; Campone, M.; Bondarenko, I.; Nowecki, Z.; Errihani, H.; Paluch-Shimon, S.; Wardley, A.; Merot, J. -l.; Trask, P.; du Toit, Y.; Pena-Murillo, C.; Revelant, V.; Klingbiel, D.; Bache ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.06.024 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study Gil-Gil, Miguel J.; Bellet, Meritxell; Bergamino, Milana; Morales, Serafin; Barnadas, Agusti; Manso, Luis; Saura, Cristina; Fernandez-Ortega, Adela; Garcia-Martinez, Elena; Martinez-Janez, Noelia; Mele, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Ma FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.645026 Green published, Gold

Más rankings

InfluScience

Contacto
Cerrar